Debtholders Can't Get $40M From US Oncology For Now
The debtholders and US Oncology disagree over language in the debt agreements' early redemption provisions that impacts how much money the debtholders are entitled to receive under the $2.16 billion McKesson deal, which included the assumption of US Oncology's debt.
US Oncology has paid...
Already a subscriber? Click here to login